HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.

AbstractPURPOSE:
Arsenic trioxide (As(2)O(3)), an inorganic arsenic compound, has recently been approved for the treatment of relapsed or refractory acute promyelocytic leukemia. However, systemic toxicity associated with As(2)O(3) treatment remains a problem. Inorganic arsenic is detoxified in vivo by methylation reactions into organic arsenic compounds that are less toxic.
METHODS AND RESULTS:
We investigated the antiproliferative and cytotoxic activity of dimethylarsinic acid (DMAA), an organic arsenic derivative and major metabolic by-product of As(2)O(3), against a panel of eight leukemia and multiple myeloma cell lines. As(2)O(3) was tested in comparison. In clonogenic assay, the average concentration of DMAA that suppressed cell colony growth by 50% was 0.5-1 m M, while for As(2)O(3) it was on average 1-2 microM. At those concentrations DMAA and As(2)O(3) had significantly less effect on colony growth of normal progenitor cells. Cytotoxic doses of DMAA and As(2)O(3) in 3-day trypan blue dye exclusion assay experiments were similar to doses effective in clonogenic assay. Assessment of apoptosis by annexin V assay revealed a high rate of apoptosis in all cell lines treated with DMAA and As(2)O(3), but significantly less effect on normal progenitor cells. DMAA, unlike As(2)O(3), had no effect on the maturation of leukemic cells.
CONCLUSIONS:
DMAA exerts differential antiproliferative and cytotoxic activity against leukemia and multiple myeloma cells, with no significant effect on normal progenitor cells. However, concentrations of DMAA needed to achieve such efficacy are up to 1000 times those of As(2)O(3). Evaluation of novel organic arsenic that would combine the high efficacy of As(2)O(3) and the low toxicity of DMAA is warranted.
AuthorsHatice Duzkale, Iman Jilani, Nada Orsolic, Ralph A Zingaro, Mirna Golemovic, Francis J Giles, Hagop Kantarjian, Maher Albitar, Emil J Freireich, Srdan Verstovsek
JournalCancer chemotherapy and pharmacology (Cancer Chemother Pharmacol) Vol. 51 Issue 5 Pg. 427-32 (May 2003) ISSN: 0344-5704 [Print] Germany
PMID12736761 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Herbicides
  • Cacodylic Acid
Topics
  • Cacodylic Acid (pharmacology)
  • Cell Death
  • Cell Division (drug effects)
  • Drug Screening Assays, Antitumor
  • Herbicides (pharmacology)
  • Humans
  • Leukemia (pathology)
  • Multiple Myeloma (pathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: